PMEL and melanoma: Therefore, the final diagnosis of primary malignant melanoma (amelanotic type) with neuroendocrine differentiation was established based on histological features and the co-expression of melanocytic and neuroendocrine markers such as Melan-A, HMB-45, and synaptophysin.